UK engineering firm Smiths Group has begun talks with the US company ICU Medical about merging the two firms’ healthcare operations.
In a statement, Smiths said it was in “very early discussions” to combine its medical unit with the rival US firm. It added, the board “routinely reviews all options for the Group’s portfolio of businesses” to maximize value for shareholders.
On Sunday evening a spokesman for Smiths Medical business confirmed that “it is in very early stage discussions about a potential combination of its medical division with ICU Medical”.
“There can be no certainty that a transaction will be concluded,” they added.
Full Content: Telegraph
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Fires Head of Copyright Office, Throwing U.S. AI Policy Into Disarray
May 12, 2025 by
CPI
Delta, Korean Air Buy Into WestJet in Major Cross-Border Deal
May 12, 2025 by
CPI
Trump Targets Big Pharma With Tough New Drug Pricing Rules
May 12, 2025 by
CPI
Geradin Partners Expands London Team with New Partner Hire
May 12, 2025 by
CPI
H-E-B Joins Antitrust Battle Against Teva Over MS Drug Monopoly
May 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece